Background Patients with acute asthma treated in the emergency department are frequently
treated with intermittent inhaled beta‐agonists delivered by nebulisation. The use of …

Background Since the late 1980s, there has been considerable clinical and academic
interest in the use of continuous aerosolized bronchodilators for the treatment of patients …

Background Inhaled beta‐agonist therapy is central to the management of acute asthma.
The use of intravenous beta‐agonist agents may also be beneficial in this setting. Objectives …

Background Inhaled beta‐agonist therapy is central to the management of acute asthma.
This review evaluates the benefit of an additional use of intravenous beta2‐agonist agents …

Background In acute asthma inhaled beta₂‐agonists are often administered by nebuliser to
relieve bronchospasm, but some have argued that metered‐dose inhalers with a holding …

Background Inhaled short‐acting beta‐2 agonists are the major class of bronchodilators
used for relief of symptoms in asthma. There has been concern that excessive uncontrolled …

Background Inhaled short‐acting anticholinergics (SAAC) and short‐acting beta₂‐agonists
(SABA) are effective therapies for adult patients with acute asthma who present to the …

BACKGROUND: In acute asthma inhaled beta-agonists are often administered to relieve
bronchospasm by wet nebulisation, but some have argued that metered-dose inhalers with …

Objectives To determine the benefit of IV β 2-agonists for severe acute asthma treated in the
emergency department (ED). Methods Randomized controlled trials were identified using …

Asthma is an important health care problem; over 12 million people in the United States
suffer from asthma, the majority of whom are young patients. Presentations of acute asthma …